Indication | Group; no. (%) of patients | |
---|---|---|
PRA n = 58 | TLA n = 41 | |
Functional | 50 (86) | 30 (73) |
Primary aldosteronism | 36 (62) | 9 (22) |
Pheochromocytoma | 6 (10) | 18 (44) |
Cushing’s syndrome | 8 (14) | 3 (7) |
Nonfunctional | 8 (14) | 11 (27) |
Adenoma | 3 (5) | 3 (7) |
Ganglioneuroma | 0 (0) | 4 (10) |
Myelolipoma | 0 (0) | 3 (7) |
Adrenocortical carcinoma | 1 (2) | 0 (0) |
Organizing hematoma | 1 (2) | 0 (0) |
Bronchogenic cyst | 1 (2) | 0 (0) |
Mucinous cystadenoma | 1 (2) | 0 (0) |
Hemangioma | 0 (0) | 1 (2) |
Cyst | 1 (2) | 0 (0) |
Lymphangioma | 0 (0) | 1 (2) |
PRA = posterior retroperitoneoscopic approach; TLA = transperitoneal laparoscopic approach.